Blue Trust Inc’s AtriCure ATRC Stock Holding History

Blue Trust Inc’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Sell	10,585 -890	-8%	-$25K	﹤0.01%	663
2026 Q1	$327K	Hold	11,475	–	–	﹤0.01%	624
2025 Q4	$454K	Sell	11,475 -495	-4%	-$18.1K	0.01%	517
2025 Q3	$422K	Sell	11,970 -460	-4%	-$15.8K	﹤0.01%	548
2025 Q2	$407K	Sell	12,430 -535	-4%	-$17.4K	﹤0.01%	522
2025 Q1	$418K	Hold	12,965	–	–	0.01%	455
2024 Q4	$396K	Sell	12,965 -1,521	-10%	-$48.9K	0.01%	443
2024 Q3	$330K	Sell	14,486 -167	-1%	-$4.12K	﹤0.01%	638
2024 Q2	$446K	Buy	14,653 +248	+2%	+$5.72K	0.01%	420
2024 Q1	$438K	Sell	14,405 -40	-0.3%	-$1.34K	0.01%	298
2023 Q4	$633K	Buy	14,445 +40	+0.3%	+$1.49K	0.01%	211
2023 Q3	$711K	Sell	14,405 -1,040	-7%	-$50.7K	0.01%	202
2023 Q2	$640K	Hold	15,445	–	–	0.01%	200
2023 Q1	$685K	Hold	15,445	–	–	0.01%	229
2022 Q4	$604K	Hold	15,445	–	–	0.01%	227
2022 Q3	$631K	Hold	15,445	–	–	0.01%	187
2022 Q2	$1.01M	Buy	+15,445	New	+$732K	0.02%	138

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Blue Trust Inc's ATRC Position: Q2 2026 in Review

Blue Trust Inc reduced its AtriCure (ATRC) stake by 7.8% in Q2 2026, selling an estimated $25K and leaving 10,585 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Blue Trust Inc first reported a position in ATRC in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.01M in Q2 2022. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Blue Trust Inc held 10,585 shares of AtriCure worth $296K as of Q2 2026.
Blue Trust Inc sold 890 AtriCure shares in Q2 2026, an estimated $25K.
AtriCure made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #663 holding.
Blue Trust Inc first reported a position in AtriCure in Q2 2022 and has held it in 17 quarters since.
Blue Trust Inc's AtriCure position peaked at $1.01M in Q2 2022.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.